Foresite Capital Management IV, LLC

Position in CYTK — Cytokinetics Inc

CIK 1704132 West Hollywood, CA

Position in CYTK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$60,884,867

+$27,712,694 QoQ

Shares Held

714,695

+42.0% QoQ

Ownership

0.514%

of shares outstanding

% of Portfolio

20.98%

of 13F equity value

Holder Rank

#45

of 477 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Foresite Capital Management IV, LLC holds $290,151,347 across 6 Biotechnology names. CYTK ranks #2 (21.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PHVS	Pharvaris N.V.	4,778,581	$165,243,330
2	CYTK	Cytokinetics Inc This page	714,695	$60,884,867
3	EIKN	Eikon Therapeutics, Inc.	1,943,682	$25,365,050
4	RLAY	Relay Therapeutics, Inc.	1,250,000	$23,387,500
5	XENE	Xenon Pharmaceuticals Inc.	160,000	$9,657,600
6	CRNX	Crinetics Pharmaceuticals, Inc.	150,000	$5,613,000

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$60,884,867	714,695	+42.0%	Shares	Sole	2026-08-14
2026-03-31	$33,172,173	503,295	+9.8%	Shares	Sole	2026-05-15
2025-12-31	$29,120,064	458,295	0.0%	Shares	Sole	2026-02-17
2025-09-30	$25,187,893	458,295	-15.9%	Shares	Sole	2025-11-14
2021-06-30	$10,787,548	545,101	-38.2%	Shares	Sole	2021-08-16
2021-03-31	$20,513,017	881,901	-38.6%	Shares	Sole	2021-05-17
2020-12-31	$29,839,913	1,435,992	-14.1%	Shares	Sole	2021-02-16
2020-09-30	$36,205,121	1,672,292	+4.0%	Shares	Sole	2020-11-13
2020-06-30	$37,883,872	1,607,292	-26.2%	Shares	Sole	2020-08-13
2020-03-31	$25,670,272	2,177,292	—	Shares	Sole	2020-05-28
No filing history on record for this holder in this stock.